United States · FDA National Drug Code directory

Isturisa

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
55292-320_5c1e5bfa-9d7b-4a4a-b030-caf7bb57c6df
Product NDC
55292-320
Form
TABLET, COATED
Composition / generic term
osilodrostat
Labeler
Recordati Rare Diseases, Inc.
Marketing category
NDA
Marketing start / end (source format)
20200331 / 20291231

Source-listed ingredients

  • OSILODROSTAT PHOSPHATE — 1 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 20 TABLET, COATED in 1 BLISTER PACK (55292-320-20) · 55292-320-20
  • 60 TABLET, COATED in 1 BLISTER PACK (55292-320-60) · 55292-320-60

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →